Title : Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?

Pub. Date : 2020 Jun

PMID : 32041467






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Olaparib is a first-in-class PARP inhibitor that has demonstrated efficacy as maintenance therapy in patients with ovarian cancer. olaparib collagen type XI alpha 2 chain Homo sapiens